Andreas Naros

Dr. Andreas Naros

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
ANAndreas Naros
Andreas Naros
HWHannes Weise
Hannes Weise
FTFelix Tilsen
Felix Tilsen
SHSebastian Hoefert
Sebastian Hoefert
GNGeorgios Naros
Georgios Naros
JPJoachim Polligkeit
Joachim Polligkeit

1 October 2018 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
ANAndreas Naros
Andreas Naros
ABAnnekathrin Brocks
Annekathrin Brocks
SKSusanne Kluba
Susanne Kluba
SRSiegmar Reinert
Siegmar Reinert
MKMichael Krimmel
Michael Krimmel

1 March 2019 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ANAndreas Naros
Andreas Naros
JPJens Peter Peters
Jens Peter Peters
TBThorsten Biegner
Thorsten Biegner
HWHannes Weise
Hannes Weise
MKMichael Krimmel
Michael Krimmel
SRSiegmar Reinert
Siegmar Reinert

13 December 2021 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
ANAndreas Naros
Andreas Naros
SBSylva Bartel
Sylva Bartel
MBMargit D.M.D. Bacher
Margit D.M.D. Bacher
BKBernd D.M.D. Koos
Bernd D.M.D. Koos
GBGunnar Blumenstock
Gunnar Blumenstock
MKMichael M.D. Krimmel
Michael M.D. Krimmel
Background: Robin sequence is defined as the triad of micrognathia, glossoptosis, and upper airway obstruction. In up to 85 percent, it is associated with cleft palate. Many studies have reported worse speech development in Robin sequence children after cleft palate repair. The authors investigated speech development in isolated Robin sequence with cleft palate versus children with cleft palate only at the age of 5 to 6 years. Methods: All Robin sequence children were treated with the Tübingen palatal plate after birth. Data were collected using the German version of the Great Ormond Street Speech Assessment. Audio and video recordings were reviewed and analyzed separately by two blinded senior phoniatricians based on the German version of the Universal Reporting Parameters for Cleft Palate Speech, and scored to enable comparability of speech outcomes. Results: Forty-four children (Robin sequence, n = 22; cleft palate only, n = 22) were included. Robin sequence children were significantly older at surgery (11.8 months versus 7.1 months; p < 0.001) but younger at study (70.5 months versus 75.2 months; p = 0.035). They also had more severe cleft of the palate (p = 0.006). All children studied showed good to very good speech development without serious impairment. None of the reported parameters on the German version of the Universal Reporting Parameters for Cleft Palate Speech showed significant group differences; the median total score in the Robin sequence group was 23 (interquartile range, 16.5 to 27.5) versus 19 (interquartile range, 17 to 23) in the cleft palate–only group. Statistical analysis revealed no significant effect of group (Z = −1.47; p = 0.14). Conclusions: No group differences in speech development were found at age 5 to 6 years. Isolated Robin sequence does not necessarily represent a risk for impaired speech development. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.

1 April 2021 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
ANAndreas Naros
Andreas Naros
MKMichael Krimmel
Michael Krimmel
FZFranziska Zengerle
Franziska Zengerle
MBMargit Bacher
Margit Bacher
BKBernd Koos
Bernd Koos
SRSiegmar Reinert
Siegmar Reinert

19 March 2022 in Clinical Oral Investigations
Verified
Journal Article
Open access
PDF file
ANAndreas Naros
Andreas Naros
ISIrene Steiner-Wilke
Irene Steiner-Wilke
NKNadja Kaiser
Nadja Kaiser
MBMargit Bacher
Margit Bacher
BKBernd Koos
Bernd Koos
MKMichael Krimmel
Michael Krimmel
Objectives: We aimed to determine the neurocognitive development of cleft palate patients with and without Robin sequence (RS). Materials and methods: Children with isolated RS with cleft palate and children with cleft palate only (CPO) were contacted at the age of 5–6 years. All RS children had undergone initial polygraphic sleep study (PG) with a mixed-obstructive apnea index (MOAI) of ≥ 3/h and were consequently treated with the Tuebingen palatal plate. A standardized clinical examination as well as a neuropediatric and neuropsychological examination included the Wechsler Pre-school and Primary Scale of Intelligence (WPPSI-III), Kaufman Assessment Battery for Children (K-ABC), and an assessment of developmental milestones. Results: In total, 44 children (22RS, 22CPO) were included. RS children were younger at study (70.5 ± 7.3 and 75.2 ± 7.5 months; P = .035). Both groups achieved the evaluated milestones within the normed time frame. WPPSI-III and K-ABC results showed no group differences. Mean values for Verbal IQ (101.8 ± 11.1 vs. 97.1 ± 15.7), Performance IQ (102.9 ± 12.1 vs. 99.6 ± 14.5), Processing Speed Quotient (98.9 ± 15.6 vs. 94.5 ± 15.7), Full-Scale IQ (103.2 ± 12.1 vs. 98.4 ± 15.3), and Sequential Processing Scale (102.1 ± 13.1 vs. 94.2 ± 17.3) were within the reference range (IQ 85–115) for RS and CPO children, respectively, indicating average performance of both groups. Conclusion: No neurocognitive, physical, or mental impairments were detected suggesting that RS children having upper airway obstruction (UAO) treated early and effectively may use their potential for an age-appropriate neurocognitive development. Clinical relevance: Tuebingen palatal plate treatment successfully releases UAO. Thus, isolated RS does not necessarily result in developmental delay or an impaired neurocognitive outcome. Trial registration: Deutsches Register Klinischer Studien, DRKS00006831, https://www.drks.de/drks_web/